SCHEMBL29528844

SCHEMBL29528844

CN1c2ccccc2N(c2cc(-c3ccc(-c4nc5cccnc5n4C)cc3)cc(-c3ccc(-c4nc5cccnc5n4C)cc3)c2N2c3ccccc3N(C)c3ccccc32)c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
MAPT P10636 2/20 0.37
DHODH Q02127 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CCNB2 O95067 1/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
CCNB3 Q8WWL7 1/20 0.34
BRD4 O60885 2/20 0.34
NPC1 O15118 3/20 0.33
PKM P14618 3/20 0.33
RAB9A P51151 3/20 0.33
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
GAA P10253 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29529527 0.91 MAPT (0.38) KDM4EMAPTMEN1KMT2ACCNB2
SCHEMBL29528496 0.90 KDM4E (0.39) KDM4EMAPTDHODHMEN1KMT2A
SCHEMBL29528712 0.89 MAPT (0.41) KDM4EMAPTMEN1KMT2ACCNB2
SCHEMBL29528249 0.85 MAPT (0.40) KDM4EMAPTMEN1KMT2ACCNB2
SCHEMBL29529088 0.84 ALDH1A1 (0.50) KDM4EMAPTMEN1KMT2ANPC1
SCHEMBL29529481 0.83 MAPT (0.39) KDM4EMAPTDHODHMEN1KMT2A
SCHEMBL29529015 0.83 MAPT (0.38) KDM4EMAPTDHODHMEN1KMT2A
SCHEMBL29528804 0.82 MAPT (0.44) KDM4EMAPTMEN1KMT2ACCNB2
SCHEMBL29529002 0.81 MAPT (0.40) KDM4EMAPTMEN1KMT2ACCNB2
SCHEMBL29528775 0.81 KDM4E (0.44) KDM4EMAPTDHODHMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11283027-B1 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2022-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11283027-B1 Composition of matter for use in organic light-emitting diodes ALDH1A2, CYBA, CRY2 KDM4E 4331/4885MAPT 214/4885DHODH 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.